Forian Inc

NASDAQ FORA

Data sourced from

and

Daily

Download Data

Forian Inc Price to Sales Ratio (P/S) on June 03, 2024: 4.32

Forian Inc Price to Sales Ratio (P/S) is 4.32 on June 03, 2024, a 44.46% change year over year. The price to sales ratio compares the market price per share of a company's stock to its sales revenue per share. It is calculated by dividing the market capitalization by the revenue, divided by the number of outstanding shares. This ratio provides insights into the market's valuation of a company's sales revenue. A higher ratio suggests that investors are willing to pay a higher price for each unit of sales revenue, indicating positive market sentiment and expectations for future revenue growth.

Forian Inc 52-week high Price to Sales Ratio (P/S) is 5.87 on March 20, 2024, which is 36.04% above the current Price to Sales Ratio (P/S).
Forian Inc 52-week low Price to Sales Ratio (P/S) is 2.59 on June 27, 2023, which is -40.10% below the current Price to Sales Ratio (P/S).
Forian Inc average Price to Sales Ratio (P/S) for the last 52 weeks is 3.68.

NASDAQ: FORA

Forian Inc

CEO	Mr. Daniel J. Barton
IPO Date	March 3, 2021
Location	United States
Headquarters	41 University Drive, Newtown, PA, United States, 18940
Employees	36
Sector	Healthcare
Industry	Health information services

Description

Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions. The company's subscription and services-based solutions cover the life sciences, pharma services, and healthcare payer and provider industries. Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania.

Key trends